DrugPatentWatch Database Preview
Teva Branded Pharm Company Profile
What is the competitive landscape for TEVA BRANDED PHARM, and what generic alternatives to TEVA BRANDED PHARM drugs are available?
TEVA BRANDED PHARM has twenty-three approved drugs.
There are forty-five US patents protecting TEVA BRANDED PHARM drugs.
There are five hundred and sixty-seven patent family members on TEVA BRANDED PHARM drugs in thirty-six countries and thirteen supplementary protection certificates in nine countries.
Summary for Teva Branded Pharm
| International Patents: | 567 |
| US Patents: | 45 |
| Tradenames: | 22 |
| Ingredients: | 13 |
| NDAs: | 23 |
| Patent Litigation for Teva Branded Pharm: | See patent lawsuits for Teva Branded Pharm |
Drugs and US Patents for Teva Branded Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | VANTRELA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 207975-004 | Jan 17, 2017 | DISCN | Yes | No | 9,216,176 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Teva Branded Pharm | VANTRELA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 207975-002 | Jan 17, 2017 | DISCN | Yes | No | 8,445,018 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | DISCN | Yes | No | 1,002,251 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Teva Branded Pharm | ZECUITY | sumatriptan succinate | SYSTEM;IONTOPHORESIS | 202278-001 | Jan 17, 2013 | DISCN | Yes | No | 7,973,058 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Teva Branded Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | CENESTIN | estrogens, conjugated synthetic a | TABLET;ORAL | 020992-002 | Mar 24, 1999 | 5,908,638 | ➤ Try a Free Trial |
| Teva Branded Pharm | MIRCETTE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 020713-001 | Apr 22, 1998 | 4,921,843 | ➤ Try a Free Trial |
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | 5,776,432 | ➤ Try a Free Trial |
| Teva Branded Pharm | QVAR 80 | beclomethasone dipropionate | AEROSOL, METERED;INHALATION | 020911-001 | Sep 15, 2000 | 6,446,627 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TEVA BRANDED PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1.25 mg | ➤ Subscribe | 2008-11-03 |
| ➤ Subscribe | Tablets | 0.3 mg, 0.45 mg and 0.9 mg | ➤ Subscribe | 2009-03-19 |
| ➤ Subscribe | Tablets | 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg | ➤ Subscribe | 2013-07-10 |
| ➤ Subscribe | Tablets | 0.15 mg/0.03 mg/0.01 mg | ➤ Subscribe | 2008-01-22 |
| ➤ Subscribe | Tablets | 0.625 mg | ➤ Subscribe | 2009-03-02 |
| ➤ Subscribe | Tablets | 0.1 mg/0.02 mg and 0.01 mg | ➤ Subscribe | 2009-11-16 |
| ➤ Subscribe | Tablets | 0.15 mg/0.03 mg | ➤ Subscribe | 2004-03-29 |
Premature patent expirations for TEVA BRANDED PHARM
Expiration due to failure to pay maintenance fee
| Patent Number | Expiration Date |
|---|---|
| ➤ Try a Free Trial | ➤ Try a Free Trial |